16 related articles for article (PubMed ID: 38432956)
1. Metabolism of vesnarinone by activated neutrophils: implications for vesnarinone-induced agranulocytosis.
Uetrecht JP; Zahid N; Whitfield D
J Pharmacol Exp Ther; 1994 Sep; 270(3):865-72. PubMed ID: 7932198
[TBL] [Abstract][Full Text] [Related]
2. A Reactive Metabolite of Clozapine Induces Hematopoietic Toxicity in HL-60 Cells Undergoing Granulocytic Differentiation through Its Effect on Glutathione Metabolism.
Torii-Goto A; Yoshimi A; Tashiro Y; Ukigai M; Matsumoto A; Ozaki N; Noda Y
Biol Pharm Bull; 2022; 45(9):1232-1237. PubMed ID: 36047190
[TBL] [Abstract][Full Text] [Related]
3. Vesnarinone causes oxidative damage by inhibiting catalase function through ceramide action in myeloid cell apoptosis.
Kondo T; Suzuki Y; Kitano T; Iwai K; Watanabe M; Umehara H; Daido N; Domae N; Tashima M; Uchiyama T; Okazaki T
Mol Pharmacol; 2002 Mar; 61(3):620-7. PubMed ID: 11854443
[TBL] [Abstract][Full Text] [Related]
4. Investigation of mechanism(s) of DNA damage induced by 4-monochlorobiphenyl (PCB3) metabolites.
Xie W; Wang K; Robertson LW; Ludewig G
Environ Int; 2010 Nov; 36(8):950-61. PubMed ID: 20129669
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of bone marrow stromal cells in agranulocytosis caused by vesnarinone treatment.
Aizawa S; Nakano M; Yaguchi M; Kuriyama Y; Iwase O; Toyama K; Tanaka K; Hoshi H; Sugimoto K; Kaido A; Imai T; Nabeshima R; Handa H
Acta Haematol; 1997; 98(3):140-6. PubMed ID: 9352744
[TBL] [Abstract][Full Text] [Related]
6. Possible nonimmunological toxicological mechanisms of vesnarinone-associated agranulocytosis in HL-60 cells: role of reduced glutathione as cytotoxic defense.
Koga T; Sahara Y; Ohtani T; Yosuke K; Umehara K
J Toxicol Sci; 2024; 49(3):95-103. PubMed ID: 38432956
[TBL] [Abstract][Full Text] [Related]
7. Vesnarinone-induced granulocytopenia: incidence in Japan and recommendations for safety.
Furusawa S; Ohashi Y; Asanoi H
J Clin Pharmacol; 1996 May; 36(5):477-81. PubMed ID: 8739027
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
